BioSpace News Archive

New PSO offers confidential environment to assess safety concerns, reduce harm risk and improve safety culture free from threat of legal discovery

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, has been made aware of a lawsuit filed by Endovalve Inc. and Micro Interventional Devices, Inc

Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced today its Chief Executive Officer Ashleigh Palmer will present at the Janney Montgomery Scott Healthcare Conference being held September 17-18, 2018, at the Union League Club in New York City.

Vineti’s leading digital “platform of record” for next-generation therapies, integrating with World Courier’s global specialty logistics solution, supports commercial- and clinical-phase personalized medicines world-wide.

Continues Support of On-Site SigNature® DNA Program at Land and Maritime Since December 2014

Innovative researchers are honored for game-changing work advancing wireless and optical networking and disruptive healthcare applications

Company Plans to Submit Supplemental New Drug Applications in the US and EU

AusCann begins trading today on OTCQX under the symbol “ACNNF.”

GNC Holdings, Inc. (NYSE: GNC), a leading specialty health, wellness, and performance brand, today announced the Live Well Foundation has raised approximately $500,000 as part of the charity’s 15th Annual Golf Tournament.

Julia Gregory Brings to Cavion a Wealth of Experience and Deep Expertise in the Biopharma Industry